Numan
PrivateLast Round
Debt
Jul 16, 2025
Est. Valuation
$207.12M
Total Funding Raised
$100M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Numan operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Debt round in July 2025.
Numan is a digital health company that provides a platform for online consultations, prescription medications, and personalized treatments for various health conditions.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Numan Comparables
Compare Numan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Voy | 88% | |
| Hims & Hers Health, Inc. | 84% | |
| HeliosX | 84% |
For institutional investors. Book with your work email.
Numan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 16, 2025 | ||||
| Debt | Feb 7, 2022 | ||||
| Series B | Sep 13, 2021 | ||||
| Series A | Oct 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Numan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Debt |
| White Star Capital | Debt, Series B |
| Novator Partners | Debt, Series B, Series A |
| Colle Capital | Series B, Series A |
| Kreos Capital | Debt |
| VNV Global | Series B, Series A |
| Hanwha Asset Management | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Collaboration to design a behavioral intervention for obesity patients.
- Feb 3, 2026
Leveraging Intercom's AI tools for customer care operations.
For institutional investors. Book with your work email.
Numan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Numan's valuation, stock price, and market status.
Is Numan a public or private company?
Numan is a private company.
What is the current stock price of Numan?
Numan is a private company, so its shares have no public market price. Caplight tracks Numan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Numan worth (valuation)?
Numan's valuation is estimated at $207.1M based on funding round data.
Can I buy Numan stock?
Numan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Numan's last funding round?
Numan's most recent funding round was Debt on July 16, 2025.
Who are the main investors in Numan?
Key investors in Numan include White Star Capital, Novator Partners, Kreos Capital, Hellenic Development Bank of Investments, Novator Capital Advisers.
Will Numan IPO soon?
No public IPO plans have been announced for Numan.
How can I track Numan secondary market activity?
Caplight tracks bids, offers, and trades in Numan's shares on secondary markets.